Showing results (771-780 of 971) with videos related to
Sort By:
Pageof 98
International Journal of Cancer|December 19, 2018
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort ConsortiumRenée T Fortner, Elizabeth M Poole, Nicolas A Wentzensen, et al.JAMA Network Open|July 7, 2025
Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast CancerCharlotte Le Cornet, Audrey Y Jung, Sabine Behrens, et al.Journal of the National Cancer Institute|January 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysisZhuxuan Fu, Maria Mori Brooks, Sarah Irvin, et al.Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.The Journal of Clinical Investigation|October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancerBrad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.Veterinary Microbiology|February 13, 2021
Genomics accurately predicts antimicrobial resistance in Staphylococcus pseudintermedius collected as part of Vet-LIRN resistance monitoringGregory H Tyson, Olgica Ceric, Jake Guag, et al.The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.Journal of the National Cancer Institute|October 10, 2022
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk LociAmber A DeVries, Joe Dennis, Jonathan P Tyrer, et al.Cancer Research|December 19, 2018
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer RiskYaohua Yang, Lang Wu, Xiang Shu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.Pageof 98